Walleye Capital
CDLX icon

Walleye Capital’s Cardlytics CDLX Stock Holding History

Walleye Capital’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,000
Closed -$24.3K – 4612
2025
Q3 		$24.3K Buy
+1,000
New +$16.7K ﹤0.01% 4179
2025
Q2 		– Sell
-2,830
Closed -$51.5K – 4551
2025
Q1 		$51.5K Sell
2,830
-5,780
-67% -$165K ﹤0.01% 3832
2024
Q4 		$319K Buy
8,610
+7,340
+578% +$281K ﹤0.01% 3369
2024
Q3 		$40.6K Sell
1,270
-870
-41% -$48.3K ﹤0.01% 4686
2024
Q2 		$176K Buy
2,140
+2,100
+5,250% +$227K ﹤0.01% 4392
2024
Q1 		$5.8K Buy
+40
New +$3.38K ﹤0.01% 5130
2020
Q1 		– Sell
-100
Closed -$63K – 1013
2019
Q4 		$63K Buy
+100
New +$48.9K ﹤0.01% 1471

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Walleye Capital's CDLX Position: Q1 2026 in Review

Walleye Capital sold out of Cardlytics (CDLX) in Q1 2026, closing a stake of 1,075 shares — an estimated $12.4K sold.

Walleye Capital first reported a position in CDLX in Q4 2019 and held it in 11 quarters. The position peaked at $766K in Q1 2023. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • Walleye Capital reported no remaining Cardlytics position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 1,075 Cardlytics shares in Q1 2026, an estimated $12.4K.
  • Walleye Capital first reported a position in Cardlytics in Q4 2019 and held it in 11 quarters.
  • Walleye Capital's Cardlytics position peaked at $766K in Q1 2023.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.